NMR blood analysis reveals metabolic vulnerability decades before disease—detecting insulin resistance, inflammation, and mortality risk from a single test that standard lipid panels miss. Biophysical chemist Jim Otvos pioneered NMR spectroscopy to measure lipoprotein particles, developing LDL particle number testing and the metabolic vulnerability index (MVX), a composite biomarker predicting mortality risk even in healthy 30-year-olds with 35+ years of follow-up data. LDL particle number (LDL-P) measured by NMR more accurately reflects cardiovascular risk than LDL cholesterol alone, especially when discordance exists between the two measures in metabolic syndrome.